Close Menu
    HCP Access Only

    New Study Finds Semaglutide Associated with Increased Risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

    Jacqueline ChinBy
    MCA Thumbnails 11 2
    MCA Thumbnails 11 2
    A recent publication in JAMA Ophthalmology has brought to light potential risks associated with the use of semaglutide, a medication often prescribed for managing type 2 diabetes (T2D) and obesity.

    Log In or Register as a healthcare professional to read the full article.

    Share.
    cropped WhatsApp Image 2024 02 15 at 14.38.02 673f33b4

    Jacqueline is a multidisciplinary scientist with extensive experience in conducting research and data analysis. She is also an avid reader and writer who aims to craft articles that inform, engage, and impact her community.

    Related Posts

    MCAsia Long Logo white e1725635014416
    Copyright © Medical Channel Asia 2024. All rights reserved.
    The contents on Medical Channel Asia are for general educational purposes only.
    It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
    See additional information.
    Existing Users Click here to login.
    Register with us by filling out the form below.
    Address Fields
    The address information you provide will be used for verifying your identity and personalizing your experience on our platform. We ensure the confidentiality and security of your address details in compliance with our privacy policy.
    Identification
    Your identification details are required for secure account creation and to ensure that your profile is unique and verifiable.